Institut Cancerologie De L'ouest
Clinical trials sponsored by Institut Cancerologie De L'ouest, explained in plain language.
-
Could a common chemo drug boost the benefits of palliative radiation for advanced cancer?
Disease control TerminatedThis phase 3 trial tests whether adding the chemotherapy drug carboplatin to standard palliative radiotherapy helps control tumor growth and reduce pain better than radiotherapy alone. The study includes adults with advanced lung or head and neck cancer who need palliative radiat…
Phase: PHASE3 • Sponsor: Institut Cancerologie de l'Ouest • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Targeted bone marrow radiation tested for myeloma relapse – trial halted early
Disease control TerminatedThis early-phase study tested a combination of high-dose chemotherapy (melphalan) and escalating doses of total bone marrow irradiation, followed by a stem cell rescue, in 13 people with multiple myeloma that had returned after initial treatment. The goal was to find the highest …
Phase: NA • Sponsor: Institut Cancerologie de l'Ouest • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Relaxation therapy studied for brain tumor anxiety – but trial cut short
Symptom relief TerminatedThis study tested whether adding sophrology (a relaxation method using breathing, visualization, and gentle movement) to speech therapy could reduce anxiety in people with aggressive brain tumors. Only 13 patients were enrolled before the trial was stopped early. The goal was to …
Phase: NA • Sponsor: Institut Cancerologie de l'Ouest • Aim: Symptom relief
Last updated Jun 27, 2026 12:07 UTC